Definition

  • Autosomal dominant, inherited familial colorectal cancer syndrome due to mutation in APC gene on chromosome 5q.

    • ~75% is inherited; which means 25% arise without family history, as first mutation
  • Risk of colorectal cancer is nearly 100%

  • Gardner syndrome is a sub-type

    • Polyps + desmoid/osteomas etc

Characterised by:

  • Hundreds of colorectal adenomatous polyps at young age
  • Duodenal adenomatous polyps
  • Multiple extraintestinal manifestations
    • Ectoderm: epidermoid cyst, pilomatrixoma, CNS tumours, congenital hypertrophy of retinal pigment epithelium (CHRPE)
    • Mesoderm: connective tissue – (desmoid tumour, excessive adhesions), bone – (osteoma, exostosis, sclerosis), dental – dentigerous cyst, odontoma, supernumerary teeth, unerupted teeth)
    • Endoderm: adenomas and carcinomas of duodenum, stomach, small intestine, biliary tract, thyroid, adrenal cortex, fundic gland polyps, hepatoblastoma

Diagnosis

  • Clinical/endoscopic – over 100 colorectal adenomas.
    • Chromoendoscopy with dye spray, and random biopsies to look for microadenomas (hallmark of FAP and MAP, not in Lynch)
    • Gastroscopy may show fundic gland polyps or duodenal adenomas
  • Genetic – mutation of APC gene (only 80% of polyps affected)
  • Family history. However, 20% will be new mutations with no family history.
  • Ddx: MAP (MUTYH-associated polyposis)

Genetic testing

  • Affected family member tested first. Once mutation identified, at risk family offered simple blood test.
  • Genotype-phenotype correlation:
    • Different levels of expression, due to different site of mutation in APC gene, along with modifier genes and environment

Surveillance

  • Colonoscopy - from age 10-12 (AFAP 18-20) until colectomy at which point the rectal cuff/J pouch requires annual flexible sigmoidoscopy
  • Gastroscopy (including side viewing scope) - from age 25 and then as per the Spigelman stage
  • Thyroid USS - age 18 then eery 2-5 years

Treatment

Lower GI

Surgery

  • Should be done as early as possible. Depends on social and educational factors.
  • Options:
    • Colectomy + ileorectal anastomosis (IRA)
      • Slightly better functional outcome
  • Restorative proctocolectomy (RPC) with ileal pouch-anal anastomosis
    • Benefit of no rectum
    • Good option of high polyp burden in rectum
    • Small cuff of rectal mucosa retained at anastomosis – small risk of cancer here
    • Risk of infertility in women and sexual dysfunction in men
  • Total proctocolectomy and end ileostomy

Surveillance

  • Both procedures need annual PR and flexi sig
  • No long term evidence for NSAID or COX-2 inhibitor

Upper GI

  • Fundic gland polyps
  • Duodenal adenomas occur in nearly all patients with FAP, but malignant only in 5%

Spigelman staging

  • severity of duodenal polyposis in FAP
Points allocated
123
Number of polyps1–45–20> 20
Polyp size (mm)1–45–10> 10
Histological typeTubularTubulovillousVillous
Degree of dysplasiaMildModerateSevere
Total pointsSpigelman stageRecommended follow-up interval
005 years
1–4I5 years
5–6II3 years
7–8III1 year and consider endoscopic therapy
9–12IVConsider prophylactic duodenectomy

Treatment

  • Endoscopic removal
  • Whipples in stage IV may be required

Desmoid tumour

  • Fibromatous lesions consisting of clonal proliferations of myofibroblasts
  • 15% of FAP, mostly intraabdominal or abdominal wall, can be on extremities or trunk.
  • Histologically benign (lack nuclear atypia & features of malignancy), however can cause SBO, ureteric obstruction, intestinal ischaemia or perforation, which could be fatal.
  • Aetiology: multifactorial. Trauma e.g. operative, oestrogens, specific APC mutations
    • FAP related due to inactivation of APC and subsequent accumulation of beta-catenin in cells.
    • Sporadic desmoid usually mutation in gene for beta-catenin (uncommon for APC mutation).
  • Investigations: CT is best. MRI may be useful. USS to monitor ureters.

Treatment:

  • Observation usually preferred for asymptomatic, stable desmoids.
  • Surgical – excision (1st line for abdominal wall and extra-abdominal)
    • High recurrence rates
    • Avoided for intra-abdominal desmoids due to significant morbidity/mortality unless desmoid-related complications develop
  • Medical – NSAIDS, antioestrogens (tamoxifen), cytotoxic chemotherapy, non-cytotoxic approach – tyrosine kinase inhibitors (sorafenib, sunitinib)
  • Radiotherapy may be used.